Page last updated: 2024-10-15

AZ3451

Cross-References

ID SourceID
PubMed CID126961335
CHEMBL ID4128763
CHEBI ID189647

Synonyms (22)

Synonym
az-3451
2-(6-bromo-1,3-benzodioxol-5-yl)-n-(4-cyanophenyl)-1-[(1s)-1-cyclohexylethyl]-1h-benzimidazole-5-carboxamide
az3451 ,
2100284-59-9
az 3451
CHEBI:189647
S9744
gtpl9560
2-(6-bromanyl-1,3-benzodioxol-5-yl)-~{n}-(4-cyanophenyl)-1-[(1~{s})-1-cyclohexylethyl]benzimidazole-5-carboxamide
8un ,
(s)-2-(6-bromobenzo[d][1,3]dioxol-5-yl)-n-(4-cyanophenyl)-1-(1-cyclohexylethyl)-1h-benzo[d]imidazole-5-carboxamide
CS-0046379
HY-112558
mfcd31728469
BS-16462
bdbm50274114
chembl4128763 ,
AT14151
EX-A1865
2-(6-bromo-1,3-benzodioxol-5-yl)-n-(4-cyanophenyl)-1-[(1s)-1-cyclohexylethyl]benzimidazole-5-carboxamide
AKOS037649059
AC-36220

Treatment

ExcerptReference
"Treatment with AZ3451 considerably improved the mitochondrial function by restoring the mitochondrial membrane potential and increasing the levels of intracellular adenosine triphosphate (ATP)."( Protease-Activated Receptor 2 (PAR-2) Antagonist AZ3451 Mitigates Oxidized Low-Density Lipoprotein (Ox-LDL)-Induced Damage and Endothelial Inflammation.
Bai, X; Gai, J; Li, X; Liu, B; Shi, S; Sun, L; Zhao, J, 2021
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
anti-inflammatory agentAny compound that has anti-inflammatory effects.
PAR2 negative allosteric modulatornull
autophagy inducerAny compound that induces the process of autophagy (the self-digestion of one or more components of a cell through the action of enzymes originating within the same cell).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (5)

ClassDescription
secondary carboxamideA carboxamide resulting from the formal condensation of a carboxylic acid with a primary amine; formula RC(=O)NHR(1).
nitrileA compound having the structure RC#N; thus a C-substituted derivative of hydrocyanic acid, HC#N. In systematic nomenclature, the suffix nitrile denotes the triply bound #N atom, not the carbon atom attached to it.
benzimidazolesAn organic heterocyclic compound containing a benzene ring fused to an imidazole ring.
benzodioxoles
organobromine compoundA compound containing at least one carbon-bromine bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Proteinase-activated receptor 1Homo sapiens (human)IC50 (µMol)50.00000.00111.006910.0000AID1512740
Proteinase-activated receptor 2Homo sapiens (human)IC50 (µMol)3.30120.00251.34796.6000AID1497229; AID1512739
Proteinase-activated receptor 4Homo sapiens (human)IC50 (µMol)0.38000.14000.26000.3800AID1512741
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (88)

Processvia Protein(s)Taxonomy
connective tissue replacement involved in inflammatory response wound healingProteinase-activated receptor 1Homo sapiens (human)
negative regulation of glomerular filtrationProteinase-activated receptor 1Homo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processProteinase-activated receptor 1Homo sapiens (human)
inflammatory responseProteinase-activated receptor 1Homo sapiens (human)
G protein-coupled receptor signaling pathwayProteinase-activated receptor 1Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayProteinase-activated receptor 1Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationProteinase-activated receptor 1Homo sapiens (human)
protein kinase C-activating G protein-coupled receptor signaling pathwayProteinase-activated receptor 1Homo sapiens (human)
establishment of synaptic specificity at neuromuscular junctionProteinase-activated receptor 1Homo sapiens (human)
positive regulation of cell population proliferationProteinase-activated receptor 1Homo sapiens (human)
negative regulation of cell population proliferationProteinase-activated receptor 1Homo sapiens (human)
response to woundingProteinase-activated receptor 1Homo sapiens (human)
anatomical structure morphogenesisProteinase-activated receptor 1Homo sapiens (human)
platelet activationProteinase-activated receptor 1Homo sapiens (human)
regulation of blood coagulationProteinase-activated receptor 1Homo sapiens (human)
positive regulation of blood coagulationProteinase-activated receptor 1Homo sapiens (human)
positive regulation of cell migrationProteinase-activated receptor 1Homo sapiens (human)
response to lipopolysaccharideProteinase-activated receptor 1Homo sapiens (human)
regulation of interleukin-1 beta productionProteinase-activated receptor 1Homo sapiens (human)
positive regulation of interleukin-6 productionProteinase-activated receptor 1Homo sapiens (human)
positive regulation of interleukin-8 productionProteinase-activated receptor 1Homo sapiens (human)
positive regulation of collagen biosynthetic processProteinase-activated receptor 1Homo sapiens (human)
positive regulation of Rho protein signal transductionProteinase-activated receptor 1Homo sapiens (human)
dendritic cell homeostasisProteinase-activated receptor 1Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionProteinase-activated receptor 1Homo sapiens (human)
positive regulation of cysteine-type endopeptidase activity involved in apoptotic processProteinase-activated receptor 1Homo sapiens (human)
positive regulation of MAPK cascadeProteinase-activated receptor 1Homo sapiens (human)
negative regulation of neuron apoptotic processProteinase-activated receptor 1Homo sapiens (human)
positive regulation of GTPase activityProteinase-activated receptor 1Homo sapiens (human)
cell-cell junction maintenanceProteinase-activated receptor 1Homo sapiens (human)
positive regulation of DNA-templated transcriptionProteinase-activated receptor 1Homo sapiens (human)
positive regulation of vasoconstrictionProteinase-activated receptor 1Homo sapiens (human)
positive regulation of smooth muscle contractionProteinase-activated receptor 1Homo sapiens (human)
positive regulation of receptor signaling pathway via JAK-STATProteinase-activated receptor 1Homo sapiens (human)
regulation of synaptic plasticityProteinase-activated receptor 1Homo sapiens (human)
homeostasis of number of cells within a tissueProteinase-activated receptor 1Homo sapiens (human)
release of sequestered calcium ion into cytosolProteinase-activated receptor 1Homo sapiens (human)
positive regulation of release of sequestered calcium ion into cytosolProteinase-activated receptor 1Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionProteinase-activated receptor 1Homo sapiens (human)
positive regulation of calcium ion transportProteinase-activated receptor 1Homo sapiens (human)
regulation of sensory perception of painProteinase-activated receptor 1Homo sapiens (human)
platelet dense granule organizationProteinase-activated receptor 1Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeProteinase-activated receptor 1Homo sapiens (human)
thrombin-activated receptor signaling pathwayProteinase-activated receptor 1Homo sapiens (human)
trans-synaptic signaling by endocannabinoid, modulating synaptic transmissionProteinase-activated receptor 1Homo sapiens (human)
negative regulation of renin secretion into blood streamProteinase-activated receptor 1Homo sapiens (human)
vasodilationProteinase-activated receptor 2Homo sapiens (human)
T cell activation involved in immune responseProteinase-activated receptor 2Homo sapiens (human)
positive regulation of leukocyte chemotaxisProteinase-activated receptor 2Homo sapiens (human)
positive regulation of cytokine production involved in immune responseProteinase-activated receptor 2Homo sapiens (human)
positive regulation of glomerular filtrationProteinase-activated receptor 2Homo sapiens (human)
inflammatory responseProteinase-activated receptor 2Homo sapiens (human)
G protein-coupled receptor signaling pathwayProteinase-activated receptor 2Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationProteinase-activated receptor 2Homo sapiens (human)
blood coagulationProteinase-activated receptor 2Homo sapiens (human)
negative regulation of tumor necrosis factor-mediated signaling pathwayProteinase-activated receptor 2Homo sapiens (human)
regulation of blood coagulationProteinase-activated receptor 2Homo sapiens (human)
positive regulation of cell migrationProteinase-activated receptor 2Homo sapiens (human)
positive regulation of actin filament depolymerizationProteinase-activated receptor 2Homo sapiens (human)
positive regulation of pseudopodium assemblyProteinase-activated receptor 2Homo sapiens (human)
negative regulation of chemokine productionProteinase-activated receptor 2Homo sapiens (human)
positive regulation of chemokine productionProteinase-activated receptor 2Homo sapiens (human)
positive regulation of type II interferon productionProteinase-activated receptor 2Homo sapiens (human)
positive regulation of interleukin-1 beta productionProteinase-activated receptor 2Homo sapiens (human)
positive regulation of interleukin-10 productionProteinase-activated receptor 2Homo sapiens (human)
positive regulation of interleukin-6 productionProteinase-activated receptor 2Homo sapiens (human)
positive regulation of interleukin-8 productionProteinase-activated receptor 2Homo sapiens (human)
positive regulation of superoxide anion generationProteinase-activated receptor 2Homo sapiens (human)
positive regulation of toll-like receptor 2 signaling pathwayProteinase-activated receptor 2Homo sapiens (human)
negative regulation of toll-like receptor 3 signaling pathwayProteinase-activated receptor 2Homo sapiens (human)
positive regulation of toll-like receptor 3 signaling pathwayProteinase-activated receptor 2Homo sapiens (human)
positive regulation of toll-like receptor 4 signaling pathwayProteinase-activated receptor 2Homo sapiens (human)
positive regulation of Rho protein signal transductionProteinase-activated receptor 2Homo sapiens (human)
neutrophil activationProteinase-activated receptor 2Homo sapiens (human)
regulation of canonical NF-kappaB signal transductionProteinase-activated receptor 2Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionProteinase-activated receptor 2Homo sapiens (human)
positive regulation of eosinophil degranulationProteinase-activated receptor 2Homo sapiens (human)
positive regulation of GTPase activityProteinase-activated receptor 2Homo sapiens (human)
innate immune responseProteinase-activated receptor 2Homo sapiens (human)
cell-cell junction maintenanceProteinase-activated receptor 2Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIProteinase-activated receptor 2Homo sapiens (human)
regulation of JNK cascadeProteinase-activated receptor 2Homo sapiens (human)
negative regulation of JNK cascadeProteinase-activated receptor 2Homo sapiens (human)
positive regulation of JNK cascadeProteinase-activated receptor 2Homo sapiens (human)
negative regulation of insulin secretionProteinase-activated receptor 2Homo sapiens (human)
leukocyte migrationProteinase-activated receptor 2Homo sapiens (human)
positive regulation of chemotaxisProteinase-activated receptor 2Homo sapiens (human)
positive regulation of positive chemotaxisProteinase-activated receptor 2Homo sapiens (human)
defense response to virusProteinase-activated receptor 2Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionProteinase-activated receptor 2Homo sapiens (human)
positive regulation of phagocytosis, engulfmentProteinase-activated receptor 2Homo sapiens (human)
establishment of endothelial barrierProteinase-activated receptor 2Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeProteinase-activated receptor 2Homo sapiens (human)
thrombin-activated receptor signaling pathwayProteinase-activated receptor 2Homo sapiens (human)
leukocyte proliferationProteinase-activated receptor 2Homo sapiens (human)
positive regulation of neutrophil mediated killing of gram-negative bacteriumProteinase-activated receptor 2Homo sapiens (human)
mature conventional dendritic cell differentiationProteinase-activated receptor 2Homo sapiens (human)
potassium channel activating, G protein-coupled receptor signaling pathwayProteinase-activated receptor 2Homo sapiens (human)
positive regulation of renin secretion into blood streamProteinase-activated receptor 2Homo sapiens (human)
regulation of chemokine (C-X-C motif) ligand 2 productionProteinase-activated receptor 2Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayProteinase-activated receptor 2Homo sapiens (human)
signal transductionProteinase-activated receptor 4Homo sapiens (human)
blood coagulationProteinase-activated receptor 4Homo sapiens (human)
response to woundingProteinase-activated receptor 4Homo sapiens (human)
platelet activationProteinase-activated receptor 4Homo sapiens (human)
positive regulation of release of sequestered calcium ion into cytosolProteinase-activated receptor 4Homo sapiens (human)
platelet dense granule organizationProteinase-activated receptor 4Homo sapiens (human)
thrombin-activated receptor signaling pathwayProteinase-activated receptor 4Homo sapiens (human)
platelet aggregationProteinase-activated receptor 4Homo sapiens (human)
positive regulation of Rho protein signal transductionProteinase-activated receptor 4Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayProteinase-activated receptor 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (8)

Processvia Protein(s)Taxonomy
G-protein alpha-subunit bindingProteinase-activated receptor 1Homo sapiens (human)
G protein-coupled receptor activityProteinase-activated receptor 1Homo sapiens (human)
signaling receptor bindingProteinase-activated receptor 1Homo sapiens (human)
protein bindingProteinase-activated receptor 1Homo sapiens (human)
thrombin-activated receptor activityProteinase-activated receptor 1Homo sapiens (human)
G-protein beta-subunit bindingProteinase-activated receptor 1Homo sapiens (human)
G-protein alpha-subunit bindingProteinase-activated receptor 2Homo sapiens (human)
protease bindingProteinase-activated receptor 2Homo sapiens (human)
G protein-coupled receptor activityProteinase-activated receptor 2Homo sapiens (human)
signaling receptor bindingProteinase-activated receptor 2Homo sapiens (human)
protein bindingProteinase-activated receptor 2Homo sapiens (human)
thrombin-activated receptor activityProteinase-activated receptor 2Homo sapiens (human)
G-protein beta-subunit bindingProteinase-activated receptor 2Homo sapiens (human)
signaling receptor activityProteinase-activated receptor 2Homo sapiens (human)
protease bindingProteinase-activated receptor 4Homo sapiens (human)
G protein-coupled receptor activityProteinase-activated receptor 4Homo sapiens (human)
thrombin-activated receptor activityProteinase-activated receptor 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (11)

Processvia Protein(s)Taxonomy
plasma membraneProteinase-activated receptor 1Homo sapiens (human)
extracellular regionProteinase-activated receptor 1Homo sapiens (human)
early endosomeProteinase-activated receptor 1Homo sapiens (human)
late endosomeProteinase-activated receptor 1Homo sapiens (human)
Golgi apparatusProteinase-activated receptor 1Homo sapiens (human)
plasma membraneProteinase-activated receptor 1Homo sapiens (human)
caveolaProteinase-activated receptor 1Homo sapiens (human)
cell surfaceProteinase-activated receptor 1Homo sapiens (human)
platelet dense tubular networkProteinase-activated receptor 1Homo sapiens (human)
neuromuscular junctionProteinase-activated receptor 1Homo sapiens (human)
postsynaptic membraneProteinase-activated receptor 1Homo sapiens (human)
early endosomeProteinase-activated receptor 2Homo sapiens (human)
Golgi apparatusProteinase-activated receptor 2Homo sapiens (human)
plasma membraneProteinase-activated receptor 2Homo sapiens (human)
pseudopodiumProteinase-activated receptor 2Homo sapiens (human)
plasma membraneProteinase-activated receptor 2Homo sapiens (human)
extracellular regionProteinase-activated receptor 4Homo sapiens (human)
plasma membraneProteinase-activated receptor 4Homo sapiens (human)
plasma membraneProteinase-activated receptor 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (11)

Assay IDTitleYearJournalArticle
AID1497229Antagonist activity at PAR2 in human 1321N1 cells assessed as inhibition of trypsin-induced intracellular calcium flux pretreated for 60 mins followed by trypsin addition by Fluo-8 NW dye based FLIPR assay2018Bioorganic & medicinal chemistry letters, 07-15, Volume: 28, Issue:13
Isoxazole-tethered diarylheptanoid analogs: Discovery of a new drug-like PAR2 antagonist.
AID1512741Antagonist activity at human PAR42019Journal of medicinal chemistry, 01-10, Volume: 62, Issue:1
Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.
AID1409609Cytotoxicity of compound against Vero E6 cells by MTT assay.2020Nature, 07, Volume: 583, Issue:7816
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
AID1409608AUC (viral infection %) for SARS-CoV-2 in the Vero E6 cell line at 48 h by immunofluorescence-based assay (detecting the viral NP protein in the nucleus of the Vero E6 cells).2020Nature, 07, Volume: 583, Issue:7816
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
AID1409614Overall antiviral activity against SARS-CoV-2 (isolate France/IDF0372/2020) in the Vero E6 cell line at 48 h based on three assays 1) detection of viral RNA by qRT-PCR (targeting the N-gene), 2) plaque assay using lysate 3 days after addition of compound 2020Nature, 07, Volume: 583, Issue:7816
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
AID1512739Antagonist activity at human PAR22019Journal of medicinal chemistry, 01-10, Volume: 62, Issue:1
Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.
AID1409607IC50 for antiviral activity against SARS-CoV-2 in the Vero E6 cell line at 48 h by immunofluorescence-based assay (detecting the viral NP protein in the nucleus of the Vero E6 cells).2020Nature, 07, Volume: 583, Issue:7816
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
AID1409613Selectivity ratio: ratio of AUC (viral infection %) of SARS-CoV-2 in the Vero E6 cell line compared to AUC (cytotoxicity %) of compound against Vero E6 cells by MTT assay.2020Nature, 07, Volume: 583, Issue:7816
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
AID1409611AUC (cytotoxicity %) of compound against Vero E6 cells by MTT assay.2020Nature, 07, Volume: 583, Issue:7816
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
AID1512740Antagonist activity at human PAR12019Journal of medicinal chemistry, 01-10, Volume: 62, Issue:1
Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.
AID1346992Human PAR2 (Proteinase-activated receptors)2017Nature, 05-04, Volume: 545, Issue:7652
Structural insight into allosteric modulation of protease-activated receptor 2.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (71.43)24.3611
2020's2 (28.57)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]